U.S. Markets open in 23 mins.

Allergan plc (AGN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
249.07+2.66 (+1.08%)
At close: 4:03PM EDT
People also watch
BIIBCELGVRXGILDREGN
Full screen
Previous Close246.41
Open247.42
Bid247.74 x 100
Ask253.72 x 200
Day's Range247.09 - 251.63
52 Week Range184.50 - 261.27
Volume2,412,874
Avg. Volume2,210,717
Market Cap83.65B
Beta1.25
PE Ratio (TTM)7.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (1.14%)
Ex-Dividend Date2017-05-16
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com4 days ago

    Valeant Unloads Yet Another Unit

    Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund. The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018. The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load.

  • Market Realist4 days ago

    Inside Allergan’s International Business

    Allergan's International segment reported revenues of $737.3 million for 1Q17, which was 9.5% higher than the $673.3 million it reported in 1Q16.

  • Market Realist4 days ago

    How Allergan’s US General Medicines Segment Performed

    The US General Medicines segment reported revenues of $1.35 billion in 1Q17, which marked a 7.4% decline from its $1.45 billion in 1Q16.